Total Payments
$16,966
2024 Payments
$2,882
Companies
60
Transactions
1,098
Medicare Patients
6,108
Medicare Billing
$457,878
Payment Breakdown by Category
Food & Beverage$16,610 (97.9%)
Education$356.72 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,610 | 1,089 | 97.9% |
| Education | $356.72 | 9 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $2,536 | 129 | $0 (2024) |
| Janssen Biotech, Inc. | $2,070 | 107 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $1,395 | 220 | $0 (2024) |
| Dendreon Pharmaceuticals LLC | $1,135 | 50 | $0 (2024) |
| Myovant Sciences Inc. | $1,042 | 148 | $0 (2022) |
| Boston Scientific Corporation | $893.90 | 16 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $807.92 | 33 | $0 (2024) |
| COLOPLAST CORP | $769.10 | 49 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $745.74 | 47 | $0 (2024) |
| PFIZER INC. | $692.58 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,882 | 215 | Sumitomo Pharma America, Inc. ($712.33) |
| 2023 | $3,116 | 204 | Sumitomo Pharma America, Inc. ($682.83) |
| 2022 | $2,694 | 206 | Myovant Sciences Inc. ($604.89) |
| 2021 | $2,048 | 115 | Myovant Sciences Inc. ($437.11) |
| 2020 | $1,526 | 80 | Astellas Pharma US Inc ($388.32) |
| 2019 | $1,932 | 94 | Astellas Pharma US Inc ($432.72) |
| 2018 | $1,185 | 75 | Astellas Pharma US Inc ($481.76) |
| 2017 | $1,584 | 109 | Astellas Pharma US Inc ($318.34) |
All Payment Transactions
1,098 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $20.88 | General |
| Category: Prostate cancer | ||||||
| 12/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Oncology | ||||||
| 12/17/2024 | Boston Scientific Corporation | Rezum Generator (Device) | Food and Beverage | In-kind items and services | $7.35 | General |
| Category: rezum_URO | ||||||
| 12/13/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: UROLOGY | ||||||
| 12/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: UROLOGY | ||||||
| 12/05/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Oncology | ||||||
| 12/04/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.77 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $3.56 | General |
| Category: HORMONE THERAPY | ||||||
| 12/04/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: HORMONE THERAPY | ||||||
| 11/27/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: HORMONE THERAPY | ||||||
| 11/27/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $1.24 | General |
| Category: HORMONE THERAPY | ||||||
| 11/21/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $26.99 | General |
| Category: UROLOGY | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: HORMONE THERAPY | ||||||
| 11/20/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: HORMONE THERAPY | ||||||
| 11/15/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $8.97 | General |
| Category: HORMONE THERAPY | ||||||
| 11/15/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $7.07 | General |
| Category: HORMONE THERAPY | ||||||
| 11/14/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $4.49 | General |
| Category: HORMONE THERAPY | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $4.27 | General |
| Category: HORMONE THERAPY | ||||||
| 11/13/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $2.76 | General |
| Category: HORMONE THERAPY | ||||||
| 11/11/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $29.11 | General |
| Category: UROLOGY | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $25.61 | General |
| Category: Prostate cancer | ||||||
| 11/06/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: HORMONE THERAPY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,499 | 2,260 | $323,362 | $114,235 |
| 2022 | 22 | 1,711 | 2,429 | $331,023 | $125,787 |
| 2021 | 16 | 1,432 | 2,080 | $298,846 | $117,931 |
| 2020 | 17 | 1,466 | 2,110 | $281,901 | $99,925 |
Total Patients
6,108
Total Services
8,879
Medicare Billing
$457,878
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 384 | 563 | $91,769 | $46,023 | 50.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 22 | 140 | $91,000 | $18,538 | 20.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 202 | 227 | $24,970 | $12,547 | 50.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 38 | 172 | $19,092 | $10,447 | 54.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 41 | 44 | $17,292 | $7,398 | 42.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 44 | 44 | $11,000 | $4,342 | 39.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 22 | $6,798 | $2,930 | 43.1% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 20 | 20 | $8,200 | $2,871 | 35.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 21 | 21 | $5,835 | $2,088 | 35.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 19 | 19 | $3,971 | $1,898 | 47.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 451 | 628 | $6,280 | $1,377 | 21.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 144 | 185 | $24,050 | $1,297 | 5.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 26 | 47 | $5,076 | $1,172 | 23.1% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 21 | 21 | $6,174 | $930.09 | 15.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 33 | $1,485 | $345.01 | 23.2% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 19 | 74 | $370.00 | $30.46 | 8.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 367 | 490 | $79,862 | $40,004 | 50.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 234 | 262 | $28,820 | $15,154 | 52.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 50 | 268 | $29,748 | $14,752 | 49.6% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 13 | 84 | $54,600 | $11,546 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 80 | 80 | $20,000 | $9,250 | 46.3% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 47 | 49 | $19,257 | $9,080 | 47.2% |
| 55875 | Insertion of needle or tube into prostate for radiation therapy | Facility | 2022 | 11 | 11 | $15,565 | $6,631 | 42.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 35 | 38 | $7,942 | $3,965 | 49.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 21 | 21 | $6,489 | $3,204 | 49.4% |
About Dr. Carl Bruning, M.D
Dr. Carl Bruning, M.D is a Specialist healthcare provider based in Monroeville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1366447328.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carl Bruning, M.D has received a total of $16,966 in payments from pharmaceutical and medical device companies, with $2,882 received in 2024. These payments were reported across 1,098 transactions from 60 companies. The most common payment nature is "Food and Beverage" ($16,610).
As a Medicare-enrolled provider, Bruning has provided services to 6,108 Medicare beneficiaries, totaling 8,879 services with total Medicare billing of $457,878. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Monroeville, PA
- Active Since 06/16/2005
- Last Updated 07/18/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1366447328
Products in Payments
- ORGOVYX (Drug) $1,949
- ERLEADA (Drug) $1,379
- PROVENGE (Drug) $1,149
- XTANDI (Drug) $1,130
- MYRBETRIQ (Drug) $734.08
- GEMTESA (Drug) $708.19
- Nubeqa (Drug) $706.45
- XIAFLEX (Biological) $658.11
- Erleada (Drug) $460.79
- Myrbetriq (Drug) $450.24
- LYNPARZA (Drug) $441.31
- Xtandi (Drug) $431.81
- SpeediCath (Device) $336.63
- AMS 700 (Device) $321.25
- ZYTIGA (Drug) $294.30
- Androgel (Drug) $291.18
- Trelstar (Drug) $271.78
- SPACEOAR VUE (Device) $262.44
- FIRMAGON (Drug) $249.73
- TOVIAZ (Drug) $209.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Monroeville
Dr. Thomas Rosvanis, M.d, M.D
Specialist — Payments: $15,043
Specialist $15,043
Joseph Liput, M.d, M.D
Specialist — Payments: $5,783
Specialist $5,783
Zongfu Chen
Specialist — Payments: $1,791
Specialist $1,791
Dr. Satish Kanakamedala, Md, MD
Specialist — Payments: $1,334
Specialist $1,334
Deborah Whiteside
Specialist — Payments: $302.31
Specialist $302.31
Mr. Andrew Kellerman, Md, MD
Specialist — Payments: $250.13
Specialist $250.13